Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. (2022)

First Author: Anderson GSF

Attributed to: Molecular Mechanisms of Cell Death funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021015161

PubMed Identifier: 35134130

Publication URI: http://europepmc.org/abstract/MED/35134130

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 16

ISSN: 0006-4971